{'fraction_non_alphanumeric': 0.022813688212927757, 'fraction_numerical': 0.034220532319391636, 'mean_word_length': 5.426829268292683, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Reviewer Guidance Evaluation of Human Pregnancy Outcome Data DRAFT GUIDANCE

Comments and suggestions regarding this draft document should be submitted within 90 days of publication of the Federal Register notice announcing the availability of the draft guidance. Submit comments to Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers La, Rm. 1061, Rockville, MD 20857. All comments should be identified with the docket number listed in the notice of availability published in the Federal Register.